These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 37103008)
1. Blockade of Annexin A2 Prevents Early Microvasculopathy in Murine Models of Diabetic Retinopathy. Dallacasagrande V; Liu W; Almeida D; Luo M; Hajjar KA Invest Ophthalmol Vis Sci; 2023 Apr; 64(4):33. PubMed ID: 37103008 [TBL] [Abstract][Full Text] [Related]
2. [The expression and function of annexin A2 in the course of retinal angiogenesis of mouse]. Wang M; Yang X; Dong XG Zhonghua Yan Ke Za Zhi; 2013 Jul; 49(7):642-8. PubMed ID: 24257362 [TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor upregulates expression of annexin A2 in vitro and in a mouse model of ischemic retinopathy. Zhao S; Huang L; Wu J; Zhang Y; Pan D; Liu X Mol Vis; 2009 Jun; 15():1231-42. PubMed ID: 19536308 [TBL] [Abstract][Full Text] [Related]
4. Intravitreal Delivery of VEGF-A Mezu-Ndubuisi OJ; Wang Y; Schoephoerster J; Falero-Perez J; Zaitoun IS; Sheibani N; Gong S Curr Eye Res; 2019 Mar; 44(3):275-286. PubMed ID: 30383455 [TBL] [Abstract][Full Text] [Related]
5. Annexin A2 promotes development of retinal neovascularization through PI3K/ AKT signaling pathway. Li C; Zhao Z; Zhao S Curr Eye Res; 2022 Apr; 47(4):579-589. PubMed ID: 34894941 [TBL] [Abstract][Full Text] [Related]
6. Agents that bind annexin A2 suppress ocular neovascularization. Lima e Silva R; Shen J; Gong YY; Seidel CP; Hackett SF; Kesavan K; Jacoby DB; Campochiaro PA J Cell Physiol; 2010 Nov; 225(3):855-64. PubMed ID: 20607799 [TBL] [Abstract][Full Text] [Related]
7. Mini-peptide RPL41 attenuated retinal neovascularization by inducing degradation of ATF4 in oxygen-induced retinopathy mice. Geng W; Qin F; Ren J; Xiao S; Wang A Exp Cell Res; 2018 Aug; 369(2):243-250. PubMed ID: 29803741 [TBL] [Abstract][Full Text] [Related]
8. PF4 antagonizes retinal neovascularization via inhibiting PRAS40 phosphorylation in a mouse model of oxygen-induced retinopathy. Cai S; Yang Q; Cao Y; Li Y; Liu J; Wang J; Zhang X; Liu L; Li X; Zhang Y Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165604. PubMed ID: 31740404 [TBL] [Abstract][Full Text] [Related]
9. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade. Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470 [TBL] [Abstract][Full Text] [Related]
10. Suppression of Retinal Neovascularization by Anti-CCR3 Treatment in an Oxygen-Induced Retinopathy Model in Mice. Hirahara S; Nozaki M; Ohbayashi M; Hasegawa N; Ozone D; Ogura Y Ophthalmic Res; 2017; 58(1):56-66. PubMed ID: 28376500 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-19 Promotes Retinal Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy. Zou J; Tan W; Li B; Wang Z; Li Y; Zeng J; Jiang B; Yoshida S; Zhou Y Invest Ophthalmol Vis Sci; 2022 Jul; 63(8):9. PubMed ID: 35816041 [TBL] [Abstract][Full Text] [Related]
12. Protective effects of rapamycin on the retinal vascular bed during the vaso-obliteration phase in mouse oxygen-induced retinopathy model. Zhang J; Zhu M; Ruan L; Jiang C; Yang Q; Chang Q; Huang X FASEB J; 2020 Dec; 34(12):15822-15836. PubMed ID: 33103304 [TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice. Huang B; Deora AB; He KL; Chen K; Sui G; Jacovina AT; Almeida D; Hong P; Burgman P; Hajjar KA Blood; 2011 Sep; 118(10):2918-29. PubMed ID: 21788340 [TBL] [Abstract][Full Text] [Related]
14. Aldose reductase deficiency reduced vascular changes in neonatal mouse retina in oxygen-induced retinopathy. Fu ZJ; Li SY; Kociok N; Wong D; Chung SK; Lo AC Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5698-712. PubMed ID: 22836764 [TBL] [Abstract][Full Text] [Related]
15. Sustained intraocular vascular endothelial growth factor neutralisation does not affect retinal and choroidal vasculature in Ins2 Lechner J; Hombrebueno JR; Pedrini E; Chen M; Xu H Diab Vasc Dis Res; 2019 Sep; 16(5):440-449. PubMed ID: 31023085 [TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic effects of the DPP-4 inhibitor linagliptin via inhibition of VEGFR signalling in the mouse model of oxygen-induced retinopathy. Kolibabka M; Dietrich N; Klein T; Hammes HP Diabetologia; 2018 Nov; 61(11):2412-2421. PubMed ID: 30097694 [TBL] [Abstract][Full Text] [Related]
17. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor. Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809 [TBL] [Abstract][Full Text] [Related]
18. Insulin-Like Growth Factor Binding Protein-Related Protein 1 Inhibit Retinal Neovascularization in the Mouse Model of Oxygen-Induced Retinopathy. Zhang P; Wang H; Cao H; Xu X; Sun T J Ocul Pharmacol Ther; 2017; 33(6):459-465. PubMed ID: 28402720 [TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling. Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515 [TBL] [Abstract][Full Text] [Related]
20. Melatonin attenuated retinal neovascularization and neuroglial dysfunction by inhibition of HIF-1α-VEGF pathway in oxygen-induced retinopathy mice. Xu Y; Lu X; Hu Y; Yang B; Tsui CK; Yu S; Lu L; Liang X J Pineal Res; 2018 May; 64(4):e12473. PubMed ID: 29411894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]